Hot Features
Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Novo Nordisk A/S – Share repurchase programme Bagsværd, Denmark, 16 October 2023 – On 10 August 2023, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of...
Novo Nordisk to acquire ocedurenone for uncontrolled hypertension from KBP Biosciences Bagsværd, Denmark and Singapore, 16 October 2023 – Novo Nordisk A/S and KBP Biosciences PTE., Ltd. today...
Novo Nordisk raises sales and operating profit outlook for 2023 Bagsværd, Denmark, 13 October 2023 – Novo Nordisk today announced that the sales and operating profit growth at constant...
Novo Nordisk will stop the once-weekly injectable semaglutide kidney outcomes trial, FLOW, based on interim analysis Novo Nordisk will stop the once-weekly injectable semaglutide kidney...
Novo Nordisk A/S - share repurchase programme Bagsværd, Denmark, 09 October 2023 – On 10 August 2023, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of...
Novo Nordisk A/S - share repurchase programme Bagsværd, Denmark, 02 October 2023 – On 10 August 2023, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of...
Novo Nordisk A/S - share repurchase programme Bagsværd, Denmark, 25 September 2023 – On 10 August 2023, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of...
Valo Health and Novo Nordisk to collaborate to discover and develop novel treatments for cardiometabolic diseases using human data and artificial intelligence Collaboration will apply Valo’s...
Novo Nordisk and UNICEF to extend joint initiative to prevent global childhood obesity New York and Bagsværd, 20 September 2023 – Novo Nordisk and UNICEF today announced an extension of their...
Novo Nordisk A/S - share repurchase programme Bagsværd, Denmark, 18 September 2023 – On 10 August 2023, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 156 | 0 | 0 | 96.35 | 187 | 81.07 | 19289 | 124.61117183 | DE |
| 260 | 0 | 0 | 51.18 | 187 | 44.105 | 18028 | 94.27908713 | DE |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
